Vijaya Diagnostic Centre (VIJAYA) Q4 18/19 earnings summary

Executive summary

• FY19 consolidated revenue rose 17% YoY to ₹292.6 crore; EBITDA reached ₹105 crore, up 22%, and PAT grew 43% to ₹50 crore.

• Network covered 66+ centres across 12 cities, serving 22.91 million footfalls and offering 3,000+ tests.

Financial highlights

• Consolidated operating revenue was ₹29,258.68 lakh, up from ₹25,053.57 lakh; PAT was ₹4,968.53 lakh versus ₹3,473.31 lakh.

• Standalone operating revenue was ₹27,907.76 lakh, up 17.32% YoY; PAT rose 38.19% to ₹4,891.78 lakh.

• Consolidated operating cash flow was ₹7,692.47 lakh; investing cash outflow was ₹8,984.56 lakh and financing cash inflow was ₹642.48 lakh.

• Other income included ₹436.48 lakh in mutual-fund fair-value gains; consolidated income also included ₹173.60 lakh of liabilities written back.

Outlook and guidance

• Plans include further investment in diagnostic modalities, strategic acquisitions, expansion into new markets and deeper penetration of tier II cities.

• Long-term ambition is a network of 250+ centres across urban and rural India.